Why Diabetes Stock Insulet Soared 25% in August
Shares of Insulet (NASDAQ: PODD) rocketed 25.4% higher in August, according to data from S&P Global Market Intelligence. The stock has pumped out a gain of 108% in 2019 through Sept. 3, making it one of the year's best-performing medical device stocks within the broader healthcare arena.
The Boston-area company is the leader in tubeless insulin pump technology with its Omnipod pump.
Insulet stock's August performance is even more impressive when you consider that the market had a down month. The S&P 500, including dividends, fell 1.6% last month, and has returned 17.5% so far this year.
Source Fool.com
